Effects of Antileukotrienes in the Treatment of Asthma

This publication has 15 references indexed in Scilit:

• Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients
  BMJ, 1999
• Montelukast, a Once-Daily Leukotriene Receptor Antagonist, in the Treatment of Chronic AsthmaA Multicenter, Randomized, Double-blind Trial
  Archives of internal medicine (1960), 1998
• Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids
  Thorax, 1997
• Pharmacology of montelukast sodium (Singulair™), a potent and selective leukotriene D₄receptor antagonist
  Canadian Journal of Physiology and Pharmacology, 1995
• Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group.
  American Journal of Respiratory and Critical Care Medicine, 1994
• Acute Bronchodilation with an Intravenously Administered Leukotriene D₄Antagonist, MK-679
  American Review of Respiratory Disease, 1993
• Differential Effects of Fluticasone Propionate on Allergen-evoked Bronchoconstriction and Increased Urinary Leukotriene E₄Excretion
  American Review of Respiratory Disease, 1993
• Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist
  The Lancet, 1991
• The Preclinical Pharmacology of ICI 204,219: A Peptide Leukotriene Antagonist
  American Review of Respiratory Disease, 1990
• Leukotrienes, LTC and LTB, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases
  Journal of Allergy and Clinical Immunology, 1989